Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sarepta Therapeutics Inc

+ Add to Watchlist

SRPT:US

26.2846 USD 0.0646 0.25%

As of 11:47:25 ET on 05/26/2015.

Snapshot for Sarepta Therapeutics Inc (SRPT)

Open: 26.1300 Day's Range: 25.4087 - 26.7200 Volume: 1,165,738
Previous Close: 26.2200 52wk Range: 11.3300 - 35.4300 1-Yr Rtn: -22.94%

Stock Chart for SRPT

No chart data available.
  • SRPT:US 26.2900
  • 1D
  • 1M
  • 1Y
26.2200
Interactive SRPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -4.1299
Est. EPS (USD) (12/2015) -4.6200
Est. PEG Ratio -
Market Cap (M USD) 1,071.07
Shares Outstanding (M) 41.47
30 Day Average Volume 1,955,289
Price/Book (mrq) 5.4031
Price/Sale (ttm) 287.4836
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SRPT

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

Edward M KayeSenior VP/Interim CEOSandesh Mahatme "Sandy"Senior VP/CFO/Chief Acctg Ofcr
David Tyronne Howton "Ty"Senior VP/Secretary/Gen CnslJayant AphaleSenior VP:Technical Operations
More Company Profile & Key Executives for SRPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil